| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02ad4c9403364a2277dc906d5bc5642e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-165 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0662 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
| filingDate |
2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bd92677d7750e473120048e56b3e02e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ab1c6676a1e2534f946d6e76777028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d799bbb3026970da4070a0f2c366787d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dceec252a3cfb6ed3c7aca681e15309
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46b5f77c738e05aad487489f2270baaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_030a38d37e8d4b1f83d80ec9b056290d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3030fb6f4dce8caa6299ffd5e4d0cca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48aef3843e8233c5a37f667e7f103c79 |
| publicationDate |
2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190031459-A |
| titleOfInvention |
Method for differentiation of mesenchymal stem cells by continuous subculture of induced pluripotent stem cells |
| abstract |
The present invention relates to a medium for inducing the differentiation of degenerated stem cells into mesenchymal stem cells, a method for producing mesenchymal stem cells from degenerated stem cells using the same, and mesenchymal stem cells prepared using the same. The mesenchymal stem cells prepared using the above medium and method can be used as a cell therapy agent for congenital and acquired musculoskeletal diseases and injuries by being able to differentiate into various target cells. |
| priorityDate |
2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |